Media

The Race For Flu Test Kits | VenturePreneurs | Full Episode

March 19, 2020

In 2020, Credo Biomedical debuted its rapid flu test in the international arena. This series looks at the challenges that fledgling ventures face if they choose to go global and why some companies take the leap. Follow the founders of each company as they navigate key goals and examine whether they succeed in meeting the real-time challenges of product development and sales that they set for themselves.

Source: https://www.youtube.com/watch?v=0yVHAODos-g

Latest Posts

Expo Científica CTR 2026 Highlights

August 28, 2026

From August 10 to 12, Credo Diagnostics Biomedical participated in Expo Científica CTR 2026 in Guadalajara, Mexico, bringing together professionals from across the laboratory and

Celebrating 15 Years of Innovation: Extended Warranty Program

April 1, 2026

Since 2011, Credo Diagnostics Biomedical has been dedicated to advancing molecular diagnostics through innovative Point-of-Care testing solutions. Over the past 15 years, we have worked

Expo Científica CTR 2026 Highlights

August 28, 2026

From August 10 to 12, Credo Diagnostics Biomedical participated in Expo Científica CTR 2026 in Guadalajara, Mexico, bringing together professionals

Celebrating 15 Years of Innovation: Extended Warranty Program

April 1, 2026

Since 2011, Credo Diagnostics Biomedical has been dedicated to advancing molecular diagnostics through innovative Point-of-Care testing solutions. Over the past

Credo Preps MDx System, Multiplex Respiratory Test for US Launch

September 20, 2024

NEW YORK – Singapore-based Credo Diagnostics Biomedical is preparing to start US clinical trials fora new near-patient point-of-care molecular diagnostic system and